Boston Scientific (BSX) – ($9.08) has a Buy rating according to ValuEngine with fair value at $9.66, which makes the stock 6.00% undervalued. The one-year price target is $9.52. ValuEngine Profile – “Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.”

Analysis – The daily chart for BSX shows overbought momentum with the stock above its 21-day, 50-day and 200-day simple moving averages at $8.37, $7.88 and $6.51. My weekly value level is $8.55 with no risky levels.

Courtesy of Thomson / Reuters

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.